ATAI Life Sciences N.V.ATAI Life Sciences N.V.ATAI Life Sciences N.V.

ATAI Life Sciences N.V.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪286.26 M‬USD
−0.21USD
‪−40.22 M‬USD
‪314.00 K‬USD
‪116.12 M‬
Beta (1Y)
2.02

About ATAI Life Sciences N.V.

CEO
Florian Brand
Headquarters
Berlin
Website
Employees (FY)
83
Founded
2018
ISIN
NL0015000DX5
FIGI
BBG0107FR3K9
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ATAI is 1.73 USD — it has increased by 1.17% in the past 24 hours. Watch ATAI Life Sciences N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ATAI Life Sciences N.V. stocks are traded under the ticker ATAI.
ATAI stock has fallen by 10.36% compared to the previous week, the month change is a 9.90% fall, over the last year ATAI Life Sciences N.V. has showed a 7.49% decrease.
We've gathered analysts' opinions on ATAI Life Sciences N.V. future price: according to them, ATAI price has a max estimate of 15.00 USD and a min estimate of 6.00 USD. Watch ATAI chart and read a more detailed ATAI Life Sciences N.V. stock forecast: see what analysts think of ATAI Life Sciences N.V. and suggest that you do with its stocks.
ATAI reached its all-time high on Jun 18, 2021 with the price of 22.91 USD, and its all-time low was 1.02 USD and was reached on Dec 1, 2023. View more price dynamics on ATAI chart.
See other stocks reaching their highest and lowest prices.
ATAI stock is 9.47% volatile and has beta coefficient of 2.02. Track ATAI Life Sciences N.V. stock price on the chart and check out the list of the most volatile stocks — is ATAI Life Sciences N.V. there?
Today ATAI Life Sciences N.V. has the market capitalization of ‪286.26 M‬, it has increased by 4.06% over the last week.
Yes, you can track ATAI Life Sciences N.V. financials in yearly and quarterly reports right on TradingView.
ATAI Life Sciences N.V. is going to release the next earnings report on Aug 12, 2024. Keep track of upcoming events with our Earnings Calendar.
ATAI earnings for the last quarter are −0.17 USD per share, whereas the estimation was −0.18 USD resulting in a 6.59% surprise. The estimated earnings for the next quarter are −0.17 USD per share. See more details about ATAI Life Sciences N.V. earnings.
ATAI Life Sciences N.V. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach 0 USD.
ATAI net income for the last quarter is ‪−26.71 M‬ USD, while the quarter before that showed ‪−18.29 M‬ USD of net income which accounts for −46.04% change. Track more ATAI Life Sciences N.V. financial stats to get the full picture.
No, ATAI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 20, 2024, the company has 83.00 employees. See our rating of the largest employees — is ATAI Life Sciences N.V. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ATAI Life Sciences N.V. EBITDA is ‪−115.79 M‬ USD, and current EBITDA margin is ‪−39.86 K‬%. See more stats in ATAI Life Sciences N.V. financial statements.
Like other stocks, ATAI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ATAI Life Sciences N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ATAI Life Sciences N.V. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ATAI Life Sciences N.V. stock shows the sell signal. See more of ATAI Life Sciences N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.